Status and phase
Conditions
Treatments
About
This is a randomized controlled pilot study investigating signals involved in drug resistance to chemotherapy.
Patient will be randomized to undergo observation or to receive Everolimus after completion of neoadjvuant treatment (anthracycline and/or taxane-based) and before surgery. The patients will be monitored for efficacy and safety.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
50 participants in 2 patient groups
Loading...
Central trial contact
Louis Chow, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal